TScan Therapeutics, Inc.
NASDAQ:TCRX
1.6 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 178.689 | 133.359 | 120.027 | 161.405 | 34.791 | 41.764 |
| Short Term Investments
| 111.421 | 58.685 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 290.11 | 192.044 | 120.027 | 161.405 | 34.791 | 41.764 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.612 | 2.193 | 4.1 | 8.498 | 1.654 | 0.615 |
| Total Current Assets
| 292.722 | 194.237 | 120.027 | 165.654 | 36.445 | 42.379 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 71.599 | 71.234 | 69.202 | 17.256 | 12.532 | 6.409 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 5.037 | 5.197 | 0.761 | 0.595 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.797 | 6.678 | 4.825 | 0 | 0 | 0 |
| Total Non-Current Assets
| 78.396 | 77.912 | 79.064 | 22.453 | 13.293 | 7.004 |
| Total Assets
| 371.118 | 272.149 | 199.091 | 188.107 | 49.738 | 49.383 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.278 | 2.374 | 2.912 | 1.765 | 2.91 | 1.01 |
| Short Term Debt
| 4.57 | 6.593 | 7.362 | 3.302 | 1.415 | 0.443 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 11.698 | 10.137 | 3.874 | 11.41 | 10.627 | 0.912 |
| Other Current Liabilities
| 15.41 | 10.716 | 3.157 | 4.866 | 2.494 | 0.943 |
| Total Current Liabilities
| 35.956 | 29.82 | 17.305 | 21.343 | 17.446 | 2.396 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 60.739 | 85.84 | 82.303 | 4.392 | -53.662 | 4.444 |
| Deferred Revenue Non-Current
| 1.246 | 5.622 | 0 | 1.497 | 8.816 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 59.681 | 0 |
| Other Non-Current Liabilities
| 32.207 | 0 | 0.049 | 0.097 | -59.443 | 59.681 |
| Total Non-Current Liabilities
| 94.192 | 91.462 | 82.352 | 5.986 | 74.754 | 64.125 |
| Total Liabilities
| 130.148 | 121.282 | 99.657 | 27.329 | 92.2 | 66.521 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 188.107 | 59.681 | 59.681 |
| Common Stock
| 0.005 | 0.005 | 0.003 | 0.003 | 0.001 | 0 |
| Retained Earnings
| -375.096 | -247.597 | -158.379 | -92.158 | -43.533 | -17.406 |
| Accumulated Other Comprehensive Income/Loss
| 0.051 | 0 | -0 | -188.107 | -59.681 | -0 |
| Other Total Stockholders Equity
| 616.01 | 398.459 | 257.81 | 441.04 | 1.07 | -59.413 |
| Total Shareholders Equity
| 240.97 | 150.867 | 99.434 | 160.778 | -42.462 | -17.138 |
| Total Equity
| 240.97 | 150.867 | 99.434 | 160.778 | -42.462 | -17.138 |
| Total Liabilities & Shareholders Equity
| 371.118 | 272.149 | 199.091 | 188.107 | 49.738 | 49.383 |